Euglycemic Clamp Profile of New Insulin Glargine U300 Formulation in Patients With Type 1 Diabetes (T1DM) Is Different from Glargine U100

被引：0
|
作者：
Tillner, Joachim
Bergmann, Karin
Teichert, Lenore
Dahmen, Raphael
Heise, Tim
Becker, Reinhard H. A.
机构：
来源：
DIABETES | 2013年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
920-P
引用
收藏
页码：A234 / A234
页数：1
相关论文
共 50 条
  • [1] New Insulin Glargine U300 Formulation Evens and Prolongs Steady State PK and PD Profiles During Euglycemic Clamp in Patients With Type 1 Diabetes (T1DM)
    Dahmen, Raphael
    Bergmann, Karin
    Lehmann, Anne
    Tillner, Joachim
    Jax, Thomas
    Heise, Tim
    Becker, Reinhard H. A.
    [J]. DIABETES, 2013, 62 : A29 - A29
  • [2] Greater Suppression of Glucagon, Lipolysis, and Ketogenesis with Insulin Glargine U300 as Compared with Glargine U100 in Type 1 Diabetes Mellitus
    Lucidi, Paola
    Porcellati, Francesca
    Cioli, Patrizia
    Candeloro, Paola
    Andreoli, Anna Marinelli
    Bolli, Geremia B.
    Fanelli, Carmine G.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 (01) : 57 - 61
  • [3] More consistent antilipolitic and antiketogenetic action of insulin Glargine U300 vs U100 in type 1 diabetes
    Lucidi, P.
    Candeloro, P.
    Andreoli, A. Marinelli
    Cioli, P.
    Bolli, G. B.
    Fanelli, C. G.
    Porcellati, F.
    [J]. DIABETOLOGIA, 2017, 60 : S307 - S307
  • [4] A Randomized Controlled Trial Comparing Glargine U300 and Glargine U100 for the Inpatient Management of Medicine and Surgery Patients with Type 2 Diabetes: Glargine U300 Hospital Trial
    Pasquel, Francisco J.
    Lansang, M. Cecilia
    Khowaja, Ameer
    Galindo, Rodolfo J.
    Urrutia, Maria A.
    Cardona, Saumeth
    Shakally, Almoutaz
    Lyerla, Ryan C.
    Anzola, Isabel
    Albury, Bonnie S.
    Haw, J. Sonya
    Fayfman, Maya
    Davis, Georgia
    Migdal, Alexandra
    Vellanki, Priyathama
    Peng, Limin
    Umpierrez, Guillermo E.
    [J]. DIABETES, 2019, 68
  • [5] A Randomized Controlled Trial Comparing Glargine U300 and Glargine U100 for the Inpatient Management of Medicine and Surgery Patients With Type 2 Diabetes: Glargine U300 Hospital Trial
    Pasquel, Francisco J.
    Lansang, M. Cecilia
    Khowaja, Ameer
    Urrutia, M. Agustina
    Cardona, Saumeth
    Albury, Bonnie
    Galindo, Rodolfo J.
    Fayfman, Maya
    Davis, Georgia
    Migdal, Alexandra
    Vellanki, Priyathama
    Peng, Limin
    Umpierrez, Guillermo E.
    [J]. DIABETES CARE, 2020, 43 (06) : 1242 - 1248
  • [6] Dosage profile of insulin glargine U100 and U300 in patients with type 2 diabetes in real clinical practice: DosInGlar study
    Duque, N.
    Artime, E.
    Romera, I.
    Lebrec, J.
    Diaz, S.
    Sicras, A.
    Reviriego, J.
    [J]. DIABETOLOGIA, 2020, 63 (SUPPL 1) : S320 - S320
  • [7] More Consistent Antilipolitic and Antiketogenetic Action of Insulin Glargine U300 vs. U100 in Type 1 Diabetes
    Lucidi, Paola
    Candeloro, Paola
    Andreoli, Anna Marinelli
    Cioli, Patrizia
    Bolli, Geremia B.
    Fanelli, Carmine G.
    Porcellati, Francesca
    [J]. DIABETES, 2017, 66 : A270 - A270
  • [8] More physiological circulating insulin and modulation of hepatic glucose production with insulin Glargine U300 vs U100 in type 1 diabetes
    Porcellati, F.
    Lucidi, P.
    Andreoli, A. Marinelli
    Cioli, P.
    Candeloro, P.
    Bolli, G. B.
    Fanelli, C. G.
    [J]. DIABETOLOGIA, 2017, 60 : S307 - S308
  • [9] Pharmacokinetics, Pharmacodynamics, and Modulation of Hepatic Glucose Production With Insulin Glargine U300 and Glargine U100 at Steady State With Individualized Clinical Doses in Type 1 Diabetes
    Porcellati, Francesca
    Lucidi, Paola
    Candeloro, Paola
    Cioli, Patrizia
    Andreoli, Anna Marinelli
    Curti, Gianluca
    Bolli, Geremia B.
    Fanelli, Carmine G.
    [J]. DIABETES CARE, 2019, 42 (01) : 85 - 92
  • [10] Experience after switching from insulin glargine U100 to glargine U300 in patients with type 1 diabetes mellitus. A study after one year of treatment in real life
    Pujante Alarcon, Pedro
    Rodriguez Escobedo, Raul
    Garcia Urruzola, Fernando
    Ares, Jessica
    Manjon, Laura
    Sanchez Ragnarson, Cecilia
    Cacho, Laura
    Delgado, Elias
    Menendez Torre, Edelmiro L.
    [J]. ENDOCRINOLOGIA DIABETES Y NUTRICION, 2019, 66 (04): : 210 - 216
12345